Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1993 1
1996 1
1997 1
1998 1
1999 1
2000 3
2001 4
2002 7
2003 8
2004 2
2005 12
2006 14
2007 38
2008 78
2009 38
2010 8
2011 7
2012 6
2013 7
2014 6
2015 10
2016 8
2017 7
2018 2
2019 5
2020 5
2021 4
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 18805841

255 results

Results by year

Filters applied: . Clear all
Page 1
Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.
Fassas A, Passweg JR, Anagnostopoulos A, Kazis A, Kozak T, Havrdova E, Carreras E, Graus F, Kashyap A, Openshaw H, Schipperus M, Deconinck E, Mancardi G, Marmont A, Hansz J, Rabusin M, Zuazu Nagore FJ, Besalduch J, Dentamaro T, Fouillard L, Hertenstein B, La Nasa G, Musso M, Papineschi F, Rowe JM, Saccardi R, Steck A, Kappos L, Gratwohl A, Tyndall A, Samijn J; Autoimmune Disease Working Party of the EBMT (European Group for Blood and Marrow Transplantation). Fassas A, et al. J Neurol. 2002 Aug;249(8):1088-97. doi: 10.1007/s00415-002-0800-7. J Neurol. 2002. PMID: 12195460 Clinical Trial.
High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis.
Shevchenko YL, Novik AA, Kuznetsov AN, Afanasiev BV, Lisukov IA, Kozlov VA, Rykavicin OA, Ionova TI, Melnichenko VY, Fedorenko DA, Kulagin AD, Shamanski SV, Ivanov RA, Gorodokin G. Shevchenko YL, et al. Exp Hematol. 2008 Aug;36(8):922-8. doi: 10.1016/j.exphem.2008.03.001. Epub 2008 May 12. Exp Hematol. 2008. PMID: 18468768 Free article. Clinical Trial.
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.
Burt RK, Loh Y, Cohen B, Stefoski D, Balabanov R, Katsamakis G, Oyama Y, Russell EJ, Stern J, Muraro P, Rose J, Testori A, Bucha J, Jovanovic B, Milanetti F, Storek J, Voltarelli JC, Burns WH. Burt RK, et al. Lancet Neurol. 2009 Mar;8(3):244-53. doi: 10.1016/S1474-4422(09)70017-1. Epub 2009 Jan 29. Lancet Neurol. 2009. PMID: 19186105 Free article. Clinical Trial.
High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy.
Verburg RJ, Kruize AA, van den Hoogen FH, Fibbe WE, Petersen EJ, Preijers F, Sont JK, Barge RM, Bijlsma JW, van de Putte LB, Breedveld FC, van Laar JM. Verburg RJ, et al. Arthritis Rheum. 2001 Apr;44(4):754-60. doi: 10.1002/1529-0131(200104)44:4<754::AID-ANR131>3.0.CO;2-N. Arthritis Rheum. 2001. PMID: 11315914 Free article. Clinical Trial.
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience.
Mancardi GL, Sormani MP, Di Gioia M, Vuolo L, Gualandi F, Amato MP, Capello E, Currò D, Uccelli A, Bertolotto A, Gasperini C, Lugaresi A, Merelli E, Meucci G, Motti L, Tola MR, Scarpini E, Repice AM, Massacesi L, Saccardi R; Italian BMT Study Group. Mancardi GL, et al. Mult Scler. 2012 Jun;18(6):835-42. doi: 10.1177/1352458511429320. Epub 2011 Nov 29. Mult Scler. 2012. PMID: 22127896
255 results